<?xml version="1.0" encoding="UTF-8"?>
<p id="Par26">Women who use drugs experience generalised social stigma and direct stigma and discrimination from health professionals, including those involved in providing harm reduction services. As in the wider public, this stigma is more acute for women than men because of social expectations about womanhood and the role of women. Women have reported pervasive stigma across the health system in studies conducted around the world [
 <xref ref-type="bibr" rid="CR4">4</xref>, 
 <xref ref-type="bibr" rid="CR41">41</xref>, 
 <xref ref-type="bibr" rid="CR42">42</xref>, 
 <xref ref-type="bibr" rid="CR45">45</xref>â€“
 <xref ref-type="bibr" rid="CR47">47</xref>]. For example, it is common for women in the UK to face open gender- and drug use-related stigma and discrimination when accessing opioid agonist therapy, particularly in pharmacies [
 <xref ref-type="bibr" rid="CR4">4</xref>].
</p>
